A practical nomogram based on serum interleukin-6 for the prognosis of liver failure

被引:3
|
作者
Xiao, Nanxi [1 ]
Liu, Linxiang [1 ]
Zhang, Yue [1 ]
Nie, Yuan [1 ]
Zhu, Xuan [1 ]
机构
[1] Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanchang, Peoples R China
基金
中国国家自然科学基金;
关键词
liver failure; inflammatory factors; diagnosis; prognosis; systemic inflammation; CIRRHOSIS; CYTOKINES; MARKERS; DISEASE;
D O I
10.3389/fmed.2022.1035699
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundLiver failure (LF) is a serious liver function damage caused by various factors, mainly jaundice, hepatic encephalopathy, coagulation disorders and multiple organ failure, with the clinical characteristic of high short-term mortality. LF is often accompanied by excessive activation of inflammatory factors, and an excessive systemic inflammatory response (i.e., inflammatory storm) is considered to be the trigger of LF. However, a specific prognostic model including inflammatory factors for patients with LF has not been well established. AimTo establish and validate a nomogram for predicting 28-day, 90-day, and 180-day mortality in patients with LF. MethodsA total of 423 eligible LF patients were enrolled in this retrospective study. Independent predictors were identified using a multivariate logistic model and then integrated into a nomogram to predict 28-day, 90-day, and 180-day mortality. The concordance index, receiver operating characteristic curves, and calibration plots were used to evaluate the performance of the model. ResultsSex, age, total bilirubin, aspartate aminotransferase, international normalized ratio, Child-Pugh score, and serum interleukin-6 were independent risk factors for death at 28, 90, and 180 days in LF patients. The nomogram showed good calibration and discrimination with an area under the receiver operating characteristic curve (AUC) of 0.927. The calibration curve fit as well, indicating that the nomogram had good clinical application value. ConclusionThis nomogram model for predicting the 28-day, 90-day, and 180-day mortality of LF patients could help optimize treatment strategies and improve prognosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] SERUM INTERLEUKIN-6 IS A PREDICTOR FOR POOR PROGNOSIS IN THE PATIENTS WITH ALCOHOLIC ACUTE-ON-CHRONIC LIVER FAILURE
    Murakami, Serami
    Imamura, Michio
    Uchida, Takuro
    Suehiro, Yosuke
    Shirane, Yuki
    Miura, Ryoichi
    Kosaka, Masanari
    Johira, Yusuke
    Yano, Shigeki
    Amioka, Kei
    Naruto, Kensuke
    Ando, Yuwa
    Uchikawa, Shinsuke
    Teraoka, Yuji
    Fujino, Hatsue
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Kawaoka, Tomokazu
    Miki, Daiki
    Aikata, Hiroshi
    [J]. HEPATOLOGY, 2022, 76 : S898 - S899
  • [2] Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
    Serami Murakami
    Michio Imamura
    Takuro Uchida
    Yosuke Suehiro
    Maiko Namba
    Yasutoshi Fujii
    Shinsuke Uchikawa
    Yuji Teraoka
    Hatsue Fujino
    Atsushi Ono
    Takashi Nakahara
    Eisuke Murakami
    Wataru Okamoto
    Masami Yamauchi
    Tomokazu Kawaoka
    Daiki Miki
    Nelson C. Hayes
    Masataka Tsuge
    Hiroshi Aikata
    Masahiro Ohira
    Hideki Ohdan
    Shiro Oka
    [J]. Hepatology International, 2023, 17 : 1225 - 1232
  • [3] Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
    Serami Murakami
    Michio Imamura
    Takuro Uchida
    Yosuke Suehiro
    Maiko Namba
    Yasutoshi Fujii
    Shinsuke Uchikawa
    Yuji Teraoka
    Hatsue Fujino
    Atsushi Ono
    Takashi Nakahara
    Eisuke Murakami
    Wataru Okamoto
    Masami Yamauchi
    Tomokazu Kawaoka
    Daiki Miki
    Nelson C. Hayes
    Masataka Tsuge
    Hiroshi Aikata
    Masahiro Ohira
    Hideki Ohdan
    Shiro Oka
    [J]. Hepatology International, 2023, 17 : 1326 - 1326
  • [4] Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients
    Tomasz Dziedzic
    Elzbieta A. Gryz
    Wojciech Turaj
    Agnieszka Slowik
    Andrzej Szczudlik
    [J]. Journal of Molecular Neuroscience, 2004, 24 : 293 - 298
  • [5] Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients
    Dziedzic, T
    Gryz, EA
    Turaj, W
    Slowik, A
    Szczudlik, A
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (02) : 293 - 298
  • [6] Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease
    Angelis, P
    Scharf, S
    Mander, A
    Vajda, F
    Christophidis, N
    [J]. NEUROSCIENCE LETTERS, 1998, 244 (02) : 106 - 108
  • [7] Interleukin-6: a neurohumoral predictor of prognosis in patients with heart failure: light and shadow
    Ferrari, R
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 (01) : 9 - 11
  • [8] EVALUATION OF SEQUENTIAL SERUM INTERLEUKIN-6 LEVELS IN LIVER ALLOGRAFT RECIPIENTS
    KITA, Y
    IWAKI, Y
    DEMETRIS, AJ
    STARZL, TE
    [J]. TRANSPLANTATION, 1994, 57 (07) : 1037 - 1041
  • [9] Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis
    Matzaraki, Vassiliki
    Alexandraki, Krystallenia I.
    Venetsanou, Kyriaki
    Piperi, Christina
    Myrianthefs, Pavlos
    Malamos, Nikolaos
    Giannakakis, Theodoros
    Karatzas, Stelios
    Diamanti-Kandarakis, Evanthia
    Baltopoulos, George
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (5-6) : 336 - 342
  • [10] SERUM INTERLEUKIN-6 IN ESSENTIAL THROMBOCYTHEMIA
    RICERCA, BM
    ROCCA, B
    DELLAVENTURA, M
    STORTI, S
    LANDOLFI, R
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1289 - 1289